North Rock Partners, LLC Astrazeneca PLC Transaction History

North Rock Partners, LLC

$1.14 Billion
Q3 2024

A detailed history of North Rock Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, North Rock Partners, LLC holds 2,742 shares of AZN stock, worth $185,414. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,742

Previous 2,780 1.37%

Holding current value

$185,414

Previous $216,000 1.39%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$76.67 - $87.62 $2,913 - $3,329	-38 Reduced 1.37%	2,742 $213,000
Q2 2024 Aug 06, 2024	BUY	$66.81 - $80.83 $185,731 - $224,707	2,780 New	2,780 $216,000
Q4 2023 Feb 08, 2024	BUY	$61.89 - $69.28 $214,572 - $240,193	3,467 New	3,467 $233,000
Q2 2023 Aug 02, 2023	SELL	$69.91 - $75.81 $9,717 - $10,537	-139 Reduced 4.22%	3,155 $225,000
Q1 2023 May 03, 2023	BUY	$63.15 - $71.6 $208,016 - $235,850	3,294 New	3,294 $228,000
Q2 2022 Aug 04, 2022	BUY	$59.26 - $71.14 $7,822 - $9,390	132 Added 1.73%	7,768 $513,000
Q1 2022 May 05, 2022	BUY	$55.72 - $67.12 $32,596 - $39,265	585 Added 8.3%	7,636 $507,000
Q4 2021 Feb 07, 2022	SELL	$54.02 - $63.83 $18,907 - $22,340	-350 Reduced 4.73%	7,051 $411,000
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $52,281 - $57,203	941 Added 14.57%	7,401 $444,000
Q1 2021 May 11, 2021	SELL	$47.16 - $54.44 $195,478 - $225,653	-4,145 Reduced 39.09%	6,460 $321,000
Q4 2020 Feb 08, 2021	SELL	$48.52 - $58.02 $442,939 - $529,664	-9,129 Reduced 46.26%	10,605 $530,000
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $725,201 - $834,931	13,665 Added 225.16%	19,734 $1.08 Million
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $215 - $276	5 Added 0.08%	6,069 $321,000
Q2 2020 Aug 11, 2020	SELL	$43.1 - $55.31 $15,429 - $19,800	-358 Reduced 5.57%	6,064 $321,000
Q1 2020 May 13, 2020	SELL	$37.79 - $51.33 $76,411 - $103,789	-2,022 Reduced 23.95%	6,422 $287,000
Q4 2019 Feb 12, 2020	SELL	$42.46 - $50.46 $249,325 - $296,301	-5,872 Reduced 41.02%	8,444 $421,000
Q4 2019 Feb 12, 2020	BUY	$42.46 - $50.46 $294,035 - $349,435	6,925 Added 93.7%	14,316 $421,000
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $296,526 - $336,068	7,391 New	7,391 $329,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $210B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.

Account

North Rock Partners, LLC Astrazeneca PLC Transaction History